OmniComm Systems, Inc. (OTCMKTS: OMCM) is a U.S.-based software company specializing in web-based solutions for the clinical research and life sciences industries. The company develops and markets enterprise-class electronic data capture (EDC) and clinical trial management systems (CTMS) designed to streamline data collection, interactive response technology (IRT) and real-time analytics. Its platforms are engineered to support the full lifecycle of Phase I–IV clinical trials, helping sponsors and research organizations reduce timelines and improve data integrity.
Founded in 1988 and headquartered in Oceanside, California, OmniComm’s flagship product, TrialMaster, offers configurable EDC functionality that enables study teams to design studies, capture and validate data, and generate reports through a secure, 21 CFR Part 11-compliant environment. The company also provides complementary modules for patient randomization, drug supply management, and electronic clinical outcome assessments (eCOA). Professional services including hosting, system validation, user training and ongoing technical support are available to ensure regulatory compliance and facilitate global study operations.
OmniComm serves pharmaceutical, biotechnology and contract research organizations (CROs) across North America, Europe and the Asia-Pacific region. Its platforms are deployed both on-premises and in cloud environments, offering scalable deployment options to meet the needs of small studies through large, multi-national programs. By combining established data management tools with configurable workflows and real-time reporting, the company aims to enhance operational efficiency and data quality for clients navigating complex regulatory landscapes.
AI Generated. May Contain Errors.
